Soybean protein isolate (SPI) was digested with protease to produce a peptides containing the lowmolecular fraction (LD3) or a mixture of high-and lowmolecular fractions (HD1). Rats were fed a diets containing SPI, LD3, or HD1 at a protein level equivalent to the 20% casein diet for 4 weeks. The serum triglyceride concentration was lower in rats fed SPI, LD3, and HD1 diets than in rats fed the casein diet, and the differences were significant for the cholesterol-enriched diet. The value for the LD3 group was the lowest among all groups for both the cholesterol-free and -enriched diets. The level of triglyceride in the post-perfused liver was significantly lower in the LD3 and HD1 groups and the SPI group than in the casein group irrespective of the presence of cholesterol in the diet. In the cholesterol-free diet, LD3 feeding as compared to casein feeding caused a reduction in triglyceride secretion from the liver to perfusate and an increment of hepatic ketone body production. The addition of cholesterol to the diets somewhat attenuated these effects of LD3. These results suggest that the low-molecular fraction in soybean peptides causes triglyceride-lowering activity through a reduction in triglyceride secretion from the liver to the blood circulation and the stimulation of fatty acid oxidation in the liver. There is a possibility that soybean peptides modulate triglyceride metabolism by changes in the hepatic contribution.
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Proteins from plant sources, such as soybean protein, are generally more hypochoelsterolemic than those from animal sources, such as casein. [1] [2] [3] [4] The hypocholesterolemic activity of soybean protein as compared with casein is known to be due to suppression of intestinal cholesterol absorption, 5, 6) promotion of fecal steroid excretion, [7] [8] [9] [10] increases in the cholesterol removal rate through the LDL receptor, 1, 3, 4) and so on. 11, 12) Soybean protein has also been found to have triglyceride-lowering action. 13, 14) Soybean protein accelerates fatty acid -oxidation and suppresses fatty acid and triglyceride syntheses in rats and mice. 1, 13, 15) In addition, the body fat-reducing effect of soybean protein has been shown in experimental animals. [16] [17] [18] Thus soybean protein has activities reducing the levels not only of cholesterol but also of triglyceride.
Soybean peptides have useful physical functional properties, viz., facility of digestion and improvement in solubility as compared to soybean protein. It has been reported that soybean peptides also have a hypocholesterolemic effect. [7] [8] [9] [10] This is because the peptides contain a high-molecular-weight (undigested) fraction, which is responsible for the stimulation of fecal steroid excretion, [7] [8] [9] [10] but the effects of soybean peptides containing a low-molecular-weight (digested) fraction on cholesterol metabolism are unclear. Also, no consistent results have been obtained for the effect of soybean peptides on triglyceride metabolism. Hence the effects of various peptides from soybean protein on cholesterol and triglyceride metabolism are obscure.
The cholesterol-and triglyceride-lowering activities of soybean protein isolate (SPI) have been reported to be induced in part by a reduction in cholesterol and triglyceride secretion from the liver to the blood circulation, 19) indicating that SPI may affects serum lipid levels through a change in hepatic function. To evaluate the effects of dietary soybean peptides on cholesterol and triglyceride levels in the serum and liver, y To whom correspondence should be addressed. Tel/Fax: +81-985-58-7212; E-mail: sakono@cc.miyazaki-u.ac.jp livers of rats fed low-molecular peptides or both highand low-molecular peptides produced from SPI were perfused, and the effects of dietary soybean peptides on triglyceride and cholesterol secretion and ketone body production in perfused livers were investigated.
Materials and Methods
Preparation of soybean peptides. Soybean protein isolate, SPI (Fujipro R, Fuji, Osaka, Japan), was added to water to a protein content of 10%, followed by artificial digestion with commercial protease (protein AY10, Amano Enzyme, Aichi, Japan) derived from bacillus species. The protease was added at the level of 4% of SPI weight, and hydrolysis was carried out at 50 C. After 5 h, this digest was heated at 85 C for 30 min to deactivate the enzyme and to sterilize it, and was cooled to 15 C and freeze-dried to produce peptides (HD1) containing high-molecular (undigested) and low-molecular (digested) fractions. The product by protease decomposition was centrifuged (1;500 Â g for 30 min) to remove the high-molecular (undigested) fraction, and consequently a supernatant was filtrated (0.45 mm, Advantec Toyo, Tokyo) and freeze-dried to produce peptides (LD3) containing only the low-molecular fraction.
Chemical analysis. The distribution of molecular weight in intact SPI and its peptides (HD1 and LD3) was analyzed by HPLC with a TSK-GEL G3000SWxl column (30 cm Â 7:8 mm, Tosoh, Tokyo). The eluant, 50 mM sodium phosphate buffer (pH 7.0) containing 1% SDS and 1.17% sodium chloride, was allowed to flow at a rate of 0.8 ml/min at 20 C. Most of the SPI molecules were more than 50,000 in molecular weight (92%), while HD1 and LD3 contained low-molecular peptides (less than 1,000 in molecular weight) at levels of 63 and 81% respectively ( Table 1 ). The chemical compositions of SPI, HD1, and LD3 were determined. The crude protein content, which was assayed by the Kjeldahl method, was 90.0, 85.0, and 90.5% in SPI, HD1, and LD3 respectively. The crude fat content, assayed by the Soxhlet method, was less than 0.3% in all preparations. Moisture content was determined as the loss in weight after drying at 105 C for 24 h, and was approximately 4% in all preparations. SPI and its peptides contained 5-6% ash as measured by the direct ignition method (heating at 540 C for 24 h). The amino acid compositions of SPI, HD1, and LD3 were also almost comparable (data not shown).
Animals and diets. Male Wistar rats weighing 70-80 g (4 weeks old) obtained from a local breeder (Kyudo, Kumamoto, Japan) were housed in individual stainlesssteel cages in an air-conditioned room (temperature, [22] [23] [24] C; relative humidity, 55-60%; lights on 7:00 to 19:00). The rats were acclimated to this artificial schedule with feeding on a powdered commercial chow (Type CE-2, Clea Japan, Tokyo) and deionized water ad libitum for 6-10 d. The animals were then divided to four groups with equal body weights. In experiment I, the diet composition was according to the formula recommended by the American Institute of Nutrition, 20) and dietary levels of SPI and its digests (LD3 and HD1) were adjusted to the basal diet (20% casein) on a nitrogenous base at the expense of sucrose. In experiment II, cholesterol and sodium cholate were added at levels of 0.5% and 0.125% respectively to the diets prepared in experiment I at the expense of sucrose. Dietary compositions are shown in Table 2 . Vitamin and mineral mixtures were purchased from Oriental Yeast (Tokyo). The rats had free access to the diets and deionized water for 4 weeks. The food consumption and body weight of each animal were recorded every day.
Liver perfusion experiment. On the day of the perfusion experiments, the rats were given intraperitoneal injections of sodium pentobarbital (5 mg/100 g body weight) around 8:30 AM. Blood was withdrawn from the portal vein just before insertion of a cannula into this vesse, followed by centrifugation at 1;000 Â g for 20 min to obtain the serum, which was stored at À80 C until lipid analysis. The livers were then isolated and placed in the perfusion apparatus after cannulation into the portal vein and superior vena cava. The livers were perfused with 120 ml of recirculating KrebsHenseleit perfusion medium (pH 7.4), which contained 25 mM glucose, 1.5% (w/v) bovine serum albumin (Fraction V, fatty acid-free, Boehringer Mannheim, Mannheim, Germany), and 25% (v/v) washed bovine erythrocytes, at a rate of 20 ml/min at 37 C. Five ml of 20 mM potassium oleate (100 mmol) as exogenous fatty acid substrate was added to the perfusion medium at the beginning of recirculation, and the same solution was continuously infused at a rate of 4.5 ml/h (90 mmol/h). Every 1 h, 20 ml of perfusate was removed for analysis of ketone bodies and lipids, and the same amount of fresh perfusion medium was added to maintain 120 ml of recirculating volume. Liver perfusion of the groups was performed at the same time and was continued for a total of 4 h. Gas containing 95% O 2 and 5% CO 2 was constantly infused into the perfusate over the perfusion period. The method and apparatus for rat liver perfusion were described in detail previously. [21] [22] [23] The experimental procedure was approved by the Ethic Committee for Animal Experiments at the University of Miyazaki.
After the end of perfusion, perfusates at each time were centrifuged at 10;000 Â g for 15 min to remove erythrocytes, followed by the measurement of ketone body production immediately. Post-perfused livers were weighed and homogenized with cold saline solution. The erythrocyte-free perfusates and liver homogenates were stored at À80 C until lipid analysis.
Analysis of ketone bodies and lipids. The concentrations of serum cholesterol and triglyceride were determined enzymatically using available commercial kits (Wako Pure Chemical Industries, Osaka, Japan). -Hydroxybutyrate and acetoacetate in a deproteinized sample of erythrocyte-free perfusates were measured using -hydroxybutyrate dehydrogenase (Boehringer Mannheim). Total lipids in perfusates and post-perfused livers were extracted and purified according to the method of Folch et al. 24) These extracts were saponified or unsaponified for measurement of the total-cholesterol or free-cholesterol concentrations, following the method of Sperry and Webb. 25) Cholesteryl ester content was calculated by subtracting free cholesterol from total cholesterol. Triglyceride concentration was measured as described previously.
26) The free fatty acid compositions of the perfusate every 1 h were analyzed by gas-liquid chromatography (GC-12A and -14A, Simadzu, Kyoto, Japan) on a Supelcowax-10 column after separation by thin-layer chromatography (n-hexane:diethyl ether:acetic acid (80:20:1, v/v/v). The free fatty acid concentration was calculated using pentadecanoic acid as the internal calibration standard.
Statistical analysis. Data were expressed as mean AE SE, and were analyzed by ANOVA 27) followed by the Tukey Kramer test to evaluate significant differences of the means among all groups.
Results

Growth parameters
The body weights, food intake, and post-perfused liver weights of rats fed the various diets are presented in Table 3 . On the cholesterol-free diet (experiment I), the final body weight tended to be higher in the LD3 group than in the other three groups, and the difference between the LD3 and SPI groups was significant. There were no significant differences in food intake among the groups. The post-perfused liver weight was significantly lower in the SPI, LD3, and HD1 groups than in the casein group. No significant differences in these parameters were observed on the cholesterol-enriched diet (experiment II). Table 4 shows the concentrations of serum and postperfused liver lipids. When the rats were fed the cholesterol-free diet (experiment I), the concentration of serum triglyceride tended to be lower when feeding SPI, LD3 (low-molecular peptide), or HD1 (high-and low-molecular peptides) than when feeding casein, and the value of the LD3 group was the lowest (65% of the casein group). The concentration of serum cholesterol tended to be lower in rats fed the diet containing SPI and HD1, but not LD3, than in rats fed casein. Feeding soybean protein, LD3 and HD1, as compared to feeding casein resulted in a significant reduction in the triglyceride level in the post-perfused liver. The concentrations of total-and free-cholesterol in the post-perfused liver were not significantly different among the groups. The proportion of cholesteryl ester to total cholesterol in the SPI, but not in the LD3 groups, was significantly lower than in the casein group, and the value of the HD1 group was intermediate between the SPI and LD3 groups.
Serum and post-perfused liver lipids
When rats were fed a cholesterol-enriched diet (experiment II), the serum triglyceride level was markedly lower in the SPI, LD3, and HD1 groups than in the Diets were prepared based on AIN-76 composition. SPI, soybean protein isolate; LD3, soybean peptides containing low-molecular fraction; HD1, soybean peptides containing low-and high-molecular fractions The additional levels of SPI, LD3, and HD1 were adjusted to 20% casein on a nitrogenous base at the expense of sucrose.
casein group, and was lowest in the LD3 group (38% of the casein group). The serum cholesterol level was comparable among all the groups. In the concentration of triglyceride in the post-perfused liver, significant reductions were observed in the SPI-, LD3-, and HD1-fed rats as compared to the casein-fed rats. The hepatic total cholesterol level was significantly lower in the HD1-fed rats than in the casein-and LD3-fed rats. There were no significant differences in the concentration of hepatic free cholesterol and the proportion of cholesteryl ester to total cholesterol among the groups.
Ketone body production Hepatic uptake of exogenous oleic acid at consecutive time intervals, which was calculated from the amounts infused and present in perfusates, were comparable among all groups in both experiment I and II (data not shown). Therefore, altered responses in ketone body production and lipid secretion by the liver might be responsible for the influenc of dietary SPI and its peptides per se. Table 5 summarizes the cumulative production of ketone bodies by the perfused liver. Ketone body Data are shown as mean AE SE for 5-6 rats. Values not sharing a common letter are significantly different at p < 0:05. SPI, soybean protein isolate; LD3, soybean peptides containing low-molecular fraction; HD1, soybean peptides containing low-and high-molecular fractions; BW, body weight Rats were fed diets supplemented with 20% casein, SPI, LD3, and HD1 in the absence or presence of 0.5% cholesterol for 4 weeks. The serum was obtained from blood in the portal vain before surgery. The livers were then isolated and perfused for 4 h in the presence of exogenous oleic acid substrate. Liver weights were measured at the end of perfusion. Data are shown as mean AE SE for 5-6 rats. Values not sharing a common letter are significantly different at p < 0:05. SPI, soybean protein isolate; LD3, soybean peptides containing low-molecular fraction; HD1, soybean peptides containing low-and high-molecular fractions The serum was obtained from blood in the portal vain before surgery. The livers were then isolated and perfused for 4 h in the presence of exogenous oleic acid substrate. The liver lipid contents were analyzed after perfusion. Cholesteryl ester (%) = (total cholesterol À free cholesterol)/total cholesterol Â 100 production, an index of enhancement of fatty acid oxidation, was approximately linear over 4 h in each group, indicating that the livers functioned normally throughout the perfusion period. On the cholesterol-free diet, although there were no significant differences in the production of ketone bodies among the four groups, the livers of rats fed diets containing LD3 tended to produce more ketone bodies than those fed diets containing casein. The ratio ofhydroxybutyrate to acetoacetate, an indication of mitochondrial redox potential, was also consistently higher in perfusates of the SPI and LD3 groups than in the casein group. On the cholesterol-enriched diet, ketone body production by the perfused liver and the ratio ofhydroxybutyrate to acetoacetate were comparable among all groups.
Triglyceride and cholesterol secretions Cumulative triglyceride and cholesterol secretions from the perfused liver into perfusates over 4 h are presented in Table 6 . On the cholesterol-free diet, hepatic triglyceride secretion was significantly lower in the LD3 group than in the casein group at 4 h. The secretion rate of triglyceride in the SPI and HD1 groups was intermediate between the casein and LD3 groups.
There were no significant differences in cholesterol secretion among the four groups. On the cholesterolenriched diet, although triglyceride secretion in the LD3 group was the lowest among all the groups, the difference was not significant. Dietary soybean peptides did not modulate hepatic secretion of cholesterol as compared with dietary casein.
Discussion
It is known that intact soybean protein relative to casein exerted hypochoelsterolemic and hypotriglyceridemic effects in various experimental animals and human subjects. [1] [2] [3] [4] These effects of soybean protein are estimated to be due partly to a reduction in cholesterol and triglyceride secretions from the liver to the blood circulation. 19) Thus dietary SPI can induce lipid-lowering activity through regulation of the hepatic contribution. In this study, to evaluate the effects of soybean peptides on serum lipid concentrations through modulation of hepatic functions, isolated livers of rats fed peptides containing low-molecular fraction (LD3) or a mixture of high-and low-molecular fractions (HD1) derived from SPI were perfused for 4 h.
On the cholesterol-free diet, dietary LD3, HD1, and Cholesterol-free diet (experiment I) Ketone body production (mmol/ SPI, as compared to dietary casein, tended to decrease the serum triglyceride level and significantly decreased the post-perfused liver triglyceride level, and such effects were most potent in the LD3 group. In the perfused liver, triglyceride secretion was significantly lower under LD3 feeding than under casein feeding. The reduction in hepatic triglyceride secretion in rats fed LD3 matched the reduction in the concentration of serum triglyceride. Also, cumulative ketone body production tended to increase in the livers of LD3-fed rats, indicating that dietary LD3 can stimulate fatty acid oxidation in the liver. In addition, the ratio ofhydroxybutyrate to acetoacetate, an index of mitochondrial redox potential, was also significantly elevated by LD3 feeding. LD3 enhanced fatty acid oxidation in the hepatic mitochondria, which led a reduction in the synthesis and secretion of triglyceride in the liver. This might be one reason for the low triglyceride concentration in the serum. Therefore, the decrease in serum triglyceride level with feeding of LD3 can be induced by modulation of the hepatic contribution, i.e., reduction of triglyceride secretion and stimulation of fatty acid oxidation. On the cholesterol-enriched diet, although serum and liver triglyceride concentrations tended to be high in the LD3 group, no stimulation of ketone body production or suppression of triglyceride secretion in the perfused liver was observed. Since synthesis of triglyceride is accelerated by the addition of cholesterol to diets, 28) there is a possibility that the effects of LD3 on triglyceride-lowering activity might have been masked on the cholesterol-enriched diet.
Although dietary HD1 also tended to lower the concentrations of serum and liver triglyceride, stimulate the production of ketone bodies, and reduce the secretion of triglyceride from the liver to the perfusate, these effects appeared to be somewhat weak as compared to dietary LD3. Because HD1 contains both high-and low-molecular peptides, the activity of HD1 on triglyceride metabolism might at least in part be exerted by low-molecular peptides in HD1. There are no reports to the effect that high-molecular peptides from soybean protein modulate hepatic triglyceride metabolism. Therefore, high-molecular peptides in HD1 do not appear to be directly responsible for the regulation of hepatic function. HD1 feeding tended to reduce serum and liver cholesterol to the same level as SPI feeding except for the serum cholesterol level on the cholesterolenriched diet, and especially the liver cholesterol concentration in cholesterol-enriched diet was significantly reduced as compared to casein feeding. This reduction with feeding HD1, peptides containing a highmolecular fraction, is thought to be in part induced through inhibition of cholesterol absorption in the intestine. Sugano et al. has shown that undigested high-molecular-weight peptides might effectively bind bile acids in the intestine and thereby increase fecal excretion of both neutral and acidic steroids, resulting in induction of the hypocholesterolemic effect. [7] [8] [9] [10] Thus, high-molecular fraction in soybean peptides can modulate cholesterol metabolism through the stimulation of fecal steroid excretion. A soybean protein-type amino acid mixture as compared to intact soybean protein has been found to attenuate hypocholesterolemic acitivities. 29) Sugano et al. have indicated that the effect of soybean protein on cholesterol metabolism might not be fully elucidated by the amino acid profile, and that the sequence of amino acid linkage and peptides formed in the process of protein digestion might be more important than amino acid composition. 19) Since the amino acid profile is comparable among the SPI, LD3, and HD1 used in the present study, the hypolipidemic activities, that is, the triglyceride-and cholesterol-lowering activities, of soybean peptides are estimated to be caused by lowmolecular peptide and high-molecular peptide per se respectively, but not the differences in amino acid composition. Concerning the action of low-molecular peptide, the oligopeptide produced by the digestion of globin has an anti-hypertriglyceridemic effect. 30) Soybean phytochemicals such as isoflavone and saponin have been demonstrated to exert hypocholesterolemic effect. [31] [32] [33] [34] Since these components might be contained in intact soybean protein and its peptides, 18) it is necessary to investigate these activities in the future.
In conclusion, we found that the low-molecular peptides produced from soybean protein decreased triglyceride secretion in rat liver as a consequence of a selective increase in ketone body production from exogenous fatty acids, resulting in a hypotriglyceridemic effect. Perhaps these low-molecular peptides are the component responsible for the hypotriglyceridemic activity of soybean protein.
